Join the 200th Anniversary Celebration

Special Article

Trends in Medicare Payments in the Last Year of Life

James D. Lubitz, and Gerald F. Riley

N Engl J Med 1993; 328:1092-1096April 15, 1993

Abstract

Background

Increased attention is being paid to the amount and types of medical services rendered in the period before death. There is a popular impression that a greater share of resources is being devoted to dying patients than in the past. We examined trends in the proportion of Medicare expenditures for persons 65 years old or older in their last year of life to determine whether there were any changes from 1976 to 1988.

Methods

Using Medicare program data for 1976, 1980, 1985, and 1988, we classified Medicare payments according to whether they were made for people in their last year of life (decedents) or for survivors. We also assigned expenses for care in the last year of life according to intervals of 30 days before the person's death and examined trends according to age.

Results

Reflecting the large overall increase in Medicare spending, Medicare costs for decedents rose from $3,488 per person-year in 1976 to $13,316 in 1988. However, Medicare payments for decedents as a percentage of the total Medicare budget changed little, fluctuating between 27.2 and 30.6 percent during the study period. Payments for care during the last 60 days of life expressed as a percentage of payments for the last year also held steady at about 52 percent. Furthermore, the pattern of lower payments for older as compared with younger decedents also prevailed throughout the study period.

Conclusions

The same forces that have acted to increase overall Medicare expenditures have affected care for both decedents and survivors. There is no evidence that persons in the last year of life account for a larger share of Medicare expenditures than in earlier years.

Media in This Article

Figure 1Distribution of Medicare Payments in the Last Year of Life, According to the Number of Days before Death, 1976 and 1988.
Table 1Medicare Enrollment and Payments, According to Survival Status, in the Four Study Years.
Article

In the past decade there has been a great deal of interest in the circumstances of a person's final days and months and in the amount of health care resources expended in the final year of life1-9. In 1978, 28 percent of Medicare program expenditures were accounted for by people in the last year of life10. The figure of 28 percent has often been misquoted, with the proportion of expenses for people in the last year of life being exaggerated and misinterpreted to mean that a large percentage of medical expenses are accounted for by terminally ill persons whose lives were prolonged by expensive techniques11-15.

The purpose of this study was to examine the trend in the proportion of all Medicare payments that is accounted for by people in the last year of life, to determine whether the proportion has changed. Since the publication of the 1984 study10 there have been two major changes in the Medicare program that may affect the amount of Medicare expenditures for those in the last year of life -- the prospective payment system for hospitals and the hospice benefit. In addition, there have been changes in the attitudes of society toward care for the dying, such as increased attention to following the wishes of the terminally ill as expressed in advance directives16.

Although data on Medicare payments for people in the last year of life cannot be used to identify which expenses were for patients who were clearly terminally ill, monitoring these payments can help identify trends in the care of beneficiaries before death. If payments for people in their last year increased more rapidly than overall Medicare payments, more attention to services received in the last months of life might be called for.

Methods

The data used in these analyses came from the Continuous Medicare History Sample, a longitudinal file on a 5 percent random sample of Medicare beneficiaries. The data on numbers of beneficiaries and dollars were multiplied by 20 to estimate totals. The file is part of the Medicare Statistical System, which compiles information from Medicare claims submitted by physicians, hospitals, and other providers. New beneficiaries are added to the Continuous Medicare History Sample, and the records of beneficiaries who die are retained in the file. Information on the use of Medicare services and dates of death is periodically added to the records of the beneficiaries.

We obtained comparable data for 1976, 1980, 1985, and 1988 on Medicare payments made on behalf of people in the last year of life. These years were chosen because 1976 was the earliest year for which data were available, and 1988 the latest, at the time the study began. Not all the tables show data for 1980 and 1985, but in no case would the data for those years have altered the conclusions.

Our sample included only Medicare beneficiaries 65 years of age or older; enrollees under the age of 65 who were entitled to Medicare because of disability were not included. The sample was restricted to Medicare beneficiaries not enrolled in health maintenance organizations (HMOs), because the records of use of Medicare services are incomplete for HMO members. The number of persons in our sample was 1,167,966 for 1976, 1,258,702 for 1980, 1,362,099 for 1985, and 1,455,424 for 1988.

The data are limited to payments for services covered by Medicare. Medicare covers hospital inpatient services, skilled-nursing services provided in a qualified skilled-nursing facility after hospitalization, home health services, services by physicians and other medical providers and suppliers, outpatient services (including those provided by hospitals, ambulatory surgical centers, and rural clinics), and hospice care (since October 1983). Important services not covered by Medicare are nursing home care not qualifying for Medicare payment and outpatient drugs. Medicare paid for only 2 percent of nursing home care in 198817.

Assignment of Costs to Decedents and Survivors

For each study year, we assigned Medicare payments either to decedents (persons in their last year of life) or to survivors (all others). In the case of the calendar year 1988, for example, beneficiaries who survived through December 31, 1989, were identified as survivors for 1988. All their person-years of enrollment in 1988 and their Medicare payments for services provided in 1988 were assigned to survivors. Person-years of enrollment and payments in 1988 for persons who died in 1988 were assigned to decedents. In addition, a portion of the payments for calendar year 1988 for persons who died in 1989 was assigned to survivors, and a portion to decedents. Payments for services during 1988 that were received within 365 days of the day of death were assigned to decedents. Any other payments for services in 1988 were assigned to survivors.

For example, if a person died on July 30, 1989, the 211th day of the year, that person would contribute the last 154 days of 1988 (i.e., 365 minus 211) to the person-year count for 1988 decedents. All Medicare payments for services provided to that person during the last 154 days of 1988 would be assigned to decedents. The first 211 days of 1988 for the same person would be assigned to the person-year count for survivors, and all payments for services provided during the first 211 days of 1988 would be assigned to survivors.

Data for hospitals and skilled-nursing facilities were assigned to survivors or decedents on the basis of the date of discharge. For example, for a 1988 decedent, the payments for a hospital stay that began in December 1987 and ended in January 1988 would be counted entirely with 1988 decedents. All hospice payments were assigned to decedents. For other services of physicians and other medical care givers and for home health care and outpatient care, the Continuous Medicare History Sample does not record the date of service but maintains only a total of payments for the calendar year. For these services, a simple algorithm was used to apportion the 1988 payments between decedents and survivors for persons dying in 1989. In the case of people dying on July 30, 1989, a total of 154/365 of the 1988 payments for these services would be assigned to decedents, and the remaining payments to survivors.

The same methods were used for the 1976, 1980, and 1985 data. To control for changes in the composition of the study population according to age and sex and in the death rates of Medicare beneficiaries from 1976 through 1988, we adjusted the payment data for 1980, 1985, and 1988 to the 1976 Medicare population.

Estimating Monthly Costs in the Last Year of Life

To estimate payments in the last year of life according to the number of months before death, we needed to overcome the limitations of the information on dates of service in the Continuous Medicare History Sample file noted above. We first categorized decedents according to the month of death and then computed annual per capita expenses for them according to the month of death. If one assumes that deaths in January occur evenly throughout the month, decedents in January have an average of 15.5 days of enrollment before death. Thus, their calendar-year expenses represent an estimate of payments made in the last 15.5 days before their deaths. Similarly, decedents in February have an average of 45 days of enrollment before death, and therefore the calendar-year expenses on their behalf approximate the expenses in the last 45 days before death. Thus, for each month we derived a value for the average number of days of enrollment for persons dying in that month, and a value for the average expenses associated with the average number of days of enrollment. Using linearizing methods described by Tukey,18 we fitted a curve to the 12 data points to provide an estimate of expenses for any particular number of days before death. In this analysis, data are presented for months defined as periods of 30 days.

Trend in the Percentage of Decedents among High-Cost Beneficiaries

We calculated the percentage of high-cost beneficiaries (defined as those for whom payments exceeded the 95th and 99th percentiles in a 12-month period) who were decedents in each of the four study years. Because this analysis required data on individual beneficiaries for a 12-month period, we chose subsamples of the decedents who died in December of each study year, because nearly 12 months of Medicare payments were reflected in their calendar-year totals. We also randomly selected 1/12 of the beneficiaries who were alive on December 31 of each study year as a sample of survivors.

These subsamples of decedents and survivors were pooled, and the 95th and 99th percentiles of Medicare payments were computed for the pooled sample for each study year. We calculated the percentage of beneficiaries in the sample for whom the payments exceeded these percentiles and who were decedents. Some of those alive on December 31 died the next year; consequently, some of the Medicare payments on their behalf during a study year were incurred during the last year of life. We treated these persons as survivors, because our purpose was to examine the trend in the relative number of high-cost decedents rather than to derive exact estimates of costs for decedents.

Standard Errors

Approximate relative standard errors were estimated on the basis of two subsamples of persons. (The relative standard error is the standard error of the estimate divided by the estimate.) The first subsample included all persons who died in December of each study year. The second included 1/12 of those alive on December 31 of each study year. We estimated the variances of the mean expenditures for decedents and survivors directly from records for the subsample. Relative standard errors for the total expenditures were estimated on the basis of formulas developed by Dr. Thomas Jabine, formerly chief mathematical statistician of the Social Security Administration. Because of large samples and consequently small relative standard errors, confidence intervals for estimates are not shown, but in each table the largest relative standard error of any estimate is noted.

Results

Payments for Decedents and Survivors

Between 1976 and 1988, the annual number of deaths among Medicare enrollees 65 years of age or older increased from 1.22 million to 1.49 million (Table 1Table 1Medicare Enrollment and Payments, According to Survival Status, in the Four Study Years.). This increase was commensurate with an increase in Medicare beneficiaries from 23.4 million to 29.1 million. The percentages of elderly Medicare beneficiaries who died in the four study years were very similar, ranging from 5.1 to 5.4 percent. The 1.49 million deaths of elderly beneficiaries in 1988 represented 69 percent of all deaths in the United States19.

The percentage of Medicare payments made on behalf of persons in the last year of life varied little during the study period (Table 1). In 1976, 28.2 percent of Medicare payments for elderly beneficiaries were made for people in the last year of life, as compared with 27.2 percent in 1988. After adjustment to the 1976 sample for changes in age and sex distribution and mortality rates, payments for persons in the last year of life constituted 28.2 percent of Medicare expenditures in 1976, 30.8 percent in 1980, 27.4 percent in 1985, and 28.6 percent in 1988.

Medicare payments grew considerably during the study period, from $3,488 per person-year in 1976 to $13,316 per person-year in 1988 for decedents and from $492 to $1,924 for survivors (Table 2Table 2Distribution of Medicare Payments, According to Type of Service and Survival Status, in the Four Study Years.). For decedents, inpatient hospital care accounted for over 70 percent of Medicare payments in each of the study years. Hospital care accounted for a smaller percentage of the total for survivors. For example, in 1988, inpatient hospital services accounted for 70.3 percent of all Medicare payments for decedents, as compared with 53.3 percent of payments for survivors. Payments for physicians and other medical services accounted for about one fifth of payments for decedents and about one third of payments for survivors.

For both decedents and survivors, inpatient hospital care accounted for a decreasing proportion of overall Medicare payments over time, with a larger decrease for survivors than for decedents. This decrease coincided with the introduction of Medicare's prospective payment system in 1983 and Peer Review Organization program in 1984.

Decedents with High Costs

Decedents made up 35 to 39 percent of the 5 percent of beneficiaries with the highest costs and 43 to 50 percent of the 1 percent of beneficiaries with the very highest costs during the study years. There was no trend over time in the percentage of high-cost beneficiaries who were decedents.

Medicare Payments According to Age

In both 1976 and 1988, Medicare payments in the last year of life generally decreased as age at death increased (Table 3Table 3Medicare Payments per Person-Year, According to Survival Status and Age, 1976 and 1988.). In 1988, Medicare payments for decedents 65 to 69 years of age averaged $15,436, whereas those for decedents 90 years of age or older averaged $8,888. For survivors in 1988, Medicare payments increased with age through the group that was 85 to 89 years old, after which they decreased.

Distribution of Payments in the Last Year of Life, According to Time before Death

In both 1976 and 1988, about half of all Medicare costs in the last year of life were incurred in the last 60 days of life, and about 40 percent were incurred in the last 30 days (Figure 1Figure 1Distribution of Medicare Payments in the Last Year of Life, According to the Number of Days before Death, 1976 and 1988.). The high proportion of expenses incurred in the last 30 days reflects the fact that over half the deaths among elderly persons occurred in the hospital20.

Discussion

The principal finding of this study is that the share of Medicare expenditures accounted for by persons in their last year of life remained virtually the same from 1976 through 1988. During this period, there was considerable growth in Medicare expenditures, with payments per person-year increasing by nearly four times both among all elderly persons and among decedents. However, the proportion of total dollars spent for decedents changed little. Apparently, the same forces that have acted to increase overall Medicare expenditures -- inflation, new techniques, and greater intensity of care -- have affected care both for decedents and for survivors.

It is perhaps not surprising that the share of the Medicare budget accounted for by beneficiaries in the last year of life did not change. First, the uncertain prognoses of many severely ill patients may limit the scope of possible changes in the care of dying patients. Because our study was retrospective, we knew which beneficiaries died. In actual practice, physicians are often unsure of a patient's prognosis21. They are faced with choices among treatments for patients who are very sick, but not necessarily dying. This point is illustrated by the finding that there were similar numbers of decedents and survivors among the 1 percent of beneficiaries for whom costs were highest.

Second, we do not know how medical costs may be affected by changes in attitudes about the appropriate amount of care for the dying. For example, an evaluation of the Medicare hospice benefit concluded that the benefit has limited potential for reducing costs for the terminally ill22. In addition, only a small proportion of Medicare decedents (3 percent in 1988) received the hospice benefit.

We found that for survivors there was a substantial shift in the location of care from the inpatient to the outpatient setting. For decedents the shift was relatively slight. The shift away from the inpatient hospital setting is thought to be due to incentives created by Medicare's prospective payment system, as well as to advances in medical techniques that permit more care to be provided on an outpatient basis23. Care for less severely ill patients, such as patients undergoing cataract surgery or hernia repair, has been shifted to outpatient settings, thereby increasing the average severity of the cases treated in the hospital24. The decreasing use of inpatient care to treat survivors probably reflects this trend. It is undoubtedly less feasible to shift much of the care for decedents to outpatient settings.

The relation between age, survival status, and the use of Medicare services also changed little between 1976 and 1988. The use of acute care services declined with age for decedents; among survivors it increased until the age of 90, after which it declined. Scitovsky also found that the use of hospitals by decedents decreased with age7. This suggests that providers may be less inclined to order aggressive interventions for the very old.

The percentage of Medicare payments made during the last year of life that were incurred during the final 60 days was virtually identical in 1976 and 1988. This suggests that “heroic” efforts to preserve life in the last few months, to whatever extent they occur, have not had a disproportionate effect on the increase in Medicare costs. If such efforts had become more frequent, one might have expected an increase in health care expenses during the final month or two as compared with the rest of the last year. This was not the case. We also found no increase in the percentage of high-cost enrollees who were decedents.

Two limitations of these results should be kept in mind. First, they pertain only to Medicare-covered services. Only a small part of all nursing home care, an important service for the elderly, is covered by Medicare. Although the use of acute care services generally declines with age among decedents, the use of nursing home care increases,5,7 and overall health expenses (including nursing home costs) do not decline substantially with age at death5,7. The second limitation is that our results reflect costs in the last year of life, not the costs of terminal illness. Our data do not indicate when the decedent's terminal illness began, which in many cases would be difficult to determine anyway.

We are left with a picture of a health care system in which spending has increased both for patients who died and for patients who survived. Our data cannot address the issue of the appropriateness of care for the terminally ill. There is no evidence, however, that increased costs for persons in the final year of life are a special problem, different in magnitude from the overall growth of Medicare expenditures.

The statements contained in this report are solely those of the authors and do not necessarily reflect the views or policies of the Health Care Financing Administration.

We are indebted to James Beebe for statistical advice, to James Greer for computer programming, and to Florence Beckman for assistance in the preparation of the manuscript.

Source Information

From the Health Care Financing Administration, 6325 Security Blvd., Rm. 2504, Oak Meadows Bldg., Baltimore, MD 21207, where reprint requests should be addressed to Mr. Lubitz.

References

References

  1. 1

    Bayer R, Callahan D, Fletcher J, et al. The care of the terminally ill: mortality and economics. N Engl J Med 1983;309:1490-1494
    Full Text | Web of Science | Medline

  2. 2

    Guralnik JM, LaCroix AZ, Branch LG, Kasl SV, Wallace RB. Morbidity and disability in older persons in the years prior to death. Am J Public Health 1991;81:443-447
    CrossRef | Web of Science | Medline

  3. 3

    Lawton MP, Moss M, Glicksman A. The quality of the last year of life of older persons. Milbank Q 1990;68:1-28
    CrossRef | Web of Science | Medline

  4. 4

    Brock DB, Holmes MB, Foley DJ, Holmes D. Methodological issues in a survey of the last days of life. In: Wallace RB, Woolson RF, eds. The epidemiologic study of the elderly. New York: Oxford University Press, 1992:315-32.

  5. 5

    Roos NP, Montgomery P, Roos LL. Health care utilization in the years prior to death. Milbank Q 1987;65:231-254
    CrossRef | Web of Science | Medline

  6. 6

    Scitovsky AA. “The high cost of dying”: what do the data show? Milbank Mem Fund Q Health Soc 1984;62:591-608
    CrossRef | Medline

  7. 7

    Scitovsky AA. Medical care in the last twelve months of life: the relation between age, functional status, and medical care expenditures. Milbank Q 1988;66:640-660
    CrossRef | Web of Science | Medline

  8. 8

    Smedira NG, Evans BH, Grais LS, et al. Withholding and withdrawal of life support from the critically ill. N Engl J Med 1990;322:309-315
    Full Text | Web of Science | Medline

  9. 9

    Spector WD, Mor V. Utilization and charges for terminal cancer patients in Rhode Island. Inquiry 1984;21:328-337
    Web of Science | Medline

  10. 10

    Lubitz J, Prihoda R. The use and costs of Medicare services in the last 2 years of life. Health Care Financ Rev 1984;5:117-131
    Medline

  11. 11

    Anderson K. Why health-care costs are tough to cure. USA Today. March 11, 1991:B3.

  12. 12

    Clark N. The high costs of dying. Wall Street Journal. February 26, 1992:A12.

  13. 13

    Freudenheim M. Medicare's woes found worsening. New York Times. September 6, 1990:A1.

  14. 14

    Morales P. We need to improve life, not prolong death. Cottage Grove Sentinel. November 7, 1990:A4.

  15. 15

    Olesker M. Tobacco lobbyist skillfully sets up a smoke screen. Baltimore Sun. January 14, 1992:D1.

  16. 16

    Emanuel LL, Barry MJ, Stoeckle JD, et al. Advance directives for medical care -- a case for greater use. N Engl J Med 1991;324:889-895
    Full Text | Web of Science | Medline

  17. 17

    Levit KR, Lazenby HC, Cowan CA, Letsch SW. National health expenditures, 1990. Health Care Financ Rev 1991;13:29-54
    Medline

  18. 18

    Tukey JW. Exploratory data analysis. Reading, Mass.: Addison-Wesley, 1977.

  19. 19

    National Center for Health Statistics. Advance report of final mortality statistics, 1988. Mon Vital Stat Rep 1990;39:Suppl-Suppl

  20. 20

    McMillan A, Mentnech RM, Lubitz J, McBean AM, Russell D. Trends and patterns in place of death for Medicare enrollees. Health Care Financ Rev 1990;12:1-7
    Medline

  21. 21

    Forster LE, Lynn J. Predicting life span for applicants to inpatient hospice. Arch Intern Med 1988;148:2540-2543
    CrossRef | Web of Science | Medline

  22. 22

    Kidder D. The effects of hospice coverage on Medicare expenditures. Health Serv Res 1992;27:195-217
    Web of Science | Medline

  23. 23

    Medicare and the American health care system: report to the Congress. Washington, D.C.: Prospective Payment Assessment Commission, 1991.

  24. 24

    The impact of the Medicare hospital prospective payment system: 1988 annual report to Congress. Washington, D.C.: Department of Health and Human Services, 1991.

Citing Articles (158)

Citing Articles

  1. 1

    Peter C. Austin, Carl van Walraven, Walter P. Wodchis, Alice Newman, Geoffrey M. Anderson. (2011) Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to Predict Mortality in a General Adult Population Cohort in Ontario, Canada. Medical Care 49:10, 932-939
    CrossRef

  2. 2

    Paresh Kumar Narayan, Seema Narayan, Russell Smyth. (2011) Is health care really a luxury in OECD countries? Evidence from alternative price deflators. Applied Economics 43:25, 3631-3643
    CrossRef

  3. 3

    Alvin C Kwok, Marcus E Semel, Stuart R Lipsitz, Angela M Bader, Amber E Barnato, Atul A Gawande, Ashish K Jha. (2011) The intensity and variation of surgical care at the end of life: a retrospective cohort study. The Lancet 378:9800, 1408-1413
    CrossRef

  4. 4

    Karen E. Steinhauser, Robert M. Arnold, Maren K. Olsen, Jennifer Lindquist, Judith Hays, Laura L. Wood, Allison M. Burton, James A. Tulsky. (2011) Comparing Three Life-Limiting Diseases: Does Diagnosis Matter or Is Sick, Sick?. Journal of Pain and Symptom Management 42:3, 331-341
    CrossRef

  5. 5

    Stephanie Alison Ward, Seema Parikh, Barbara Workman. (2011) Health perspectives: International epidemiology of ageing. Best Practice & Research Clinical Anaesthesiology 25:3, 305-317
    CrossRef

  6. 6

    Jeanie M. Youngwerth, Jess B. Bartley, Traci E. Yamashita, Jean S. Kutner. (2011) Characteristics associated with higher cost per day or longer length of stay in hospitalized patients who died during the hospitalization or were discharged to hospice. Journal of Hospital Medicine 6:6, 338-343
    CrossRef

  7. 7

    Rituparna Basu, Patrick M. Krueger, David R. Lairson, Luisa Franzini. (2011) Lifetime Medical Expenditures Among Hypertensive Men and Women in the United States. Women's Health Issues 21:3, 246-253
    CrossRef

  8. 8

    Igor Akushevich, Julia Kravchenko, Lucy Akushevich, Svetlana Ukraintseva, Konstantin Arbeev, Anatoliy I. Yashin. (2011) Medical Cost Trajectories and Onsets of Cancer and NonCancer Diseases in US Elderly Population. Computational and Mathematical Methods in Medicine 2011, 1-14
    CrossRef

  9. 9

    Sachin Logani, Adam Green, James Gasperino. (2011) Benefits of High-Intensity Intensive Care Unit Physician Staffing under the Affordable Care Act. Critical Care Research and Practice 2011, 1-7
    CrossRef

  10. 10

    Debra Sheets, Doug Kaback. (2010) Transformative Theatre: The Final Act of Living Well. Journal of Aging, Humanities, and the Arts 4:4, 377-389
    CrossRef

  11. 11

    F. Breyer, J. Costa-Font, S. Felder. (2010) Ageing, health, and health care. Oxford Review of Economic Policy 26:4, 674-690
    CrossRef

  12. 12

    Isabel Dietz, Gian Domenico Borasio, Gerhard Schneider, Ralf J. Jox. (2010) Medical Errors and Patient Safety in Palliative Care: A Review of Current Literature. Journal of Palliative Medicine 13:12, 1469-1474
    CrossRef

  13. 13

    Amir Shmueli, David Messika, Irit Zmora, Bernice Oberman. (2010) Health care costs during the last 12 months of life in Israel: estimation and implications for risk-adjustment. International Journal of Health Care Finance and Economics 10:3, 257-273
    CrossRef

  14. 14

    Thomas Shaffer, Linda Simoni-Wastila, Wendy Toler, Bruce Stuart, Jalpa A. Doshi. (2010) Changing Patterns in Medication Use with Increasing Probability of Death for Older Medicare Beneficiaries. Journal of the American Geriatrics Society 58:8, 1549-1555
    CrossRef

  15. 15

    Rajiv Sharma, Miron Stano. (2010) Implications of an economic model of health states worse than dead. Journal of Health Economics 29:4, 536-540
    CrossRef

  16. 16

    Liming Cai, James Lubitz, Katherine M. Flegal, Elsie R. Pamuk. (2010) The Predicted Effects of Chronic Obesity in Middle Age on Medicare Costs and Mortality. Medical Care 48:6, 510-517
    CrossRef

  17. 17

    Stephen Lutz, Simon S Lo, Edward Chow, Arjun Sahgal, Peter Hoskin. (2010) Radiotherapy for metastatic bone disease: current standards and future prospectus. Expert Review of Anticancer Therapy 10:5, 683-695
    CrossRef

  18. 18

    Gerald F. Riley, James D. Lubitz. (2010) Long-Term Trends in Medicare Payments in the Last Year of Life. Health Services Research 45:2, 565-576
    CrossRef

  19. 19

    Andrea C. Kronman, Karen M. Freund, Amresh Hanchate, Ezekiel J. Emanuel, Arlene S. Ash. (2010) Nursing Home Residence Confounds Gender Differences in Medicare Utilization. Women's Health Issues 20:2, 105-113
    CrossRef

  20. 20

    Stefan Felder, Andreas Werblow, Peter Zweifel. (2010) Do red herrings swim in circles? Controlling for the endogeneity of time to death. Journal of Health Economics 29:2, 205-212
    CrossRef

  21. 21

    Amber E. Barnato, Chung-Chou H. Chang, Max H. Farrell, Judith R. Lave, Mark S. Roberts, Derek C. Angus. (2010) Is Survival Better at Hospitals With Higher “End-of-Life” Treatment Intensity?. Medical Care 48:2, 125-132
    CrossRef

  22. 22

    Dana P. Goldman, Anupam B. Jena, Darius N. Lakdawalla, Jennifer L. Malin, Jesse D. Malkin, Eric Sun. (2010) The Value of Specialty Oncology Drugs. Health Services Research 45:1, 115-132
    CrossRef

  23. 23

    Andrew J. Rettenmaier, Zijun Wang. (2010) Regional variations in medical spending and utilization: a longitudinal analysis of US Medicare population. Health Economicsn/a-n/a
    CrossRef

  24. 24

    Alfons Palangkaraya, Jongsay Yong. (2009) Population ageing and its implications on aggregate health care demand: empirical evidence from 22 OECD countries. International Journal of Health Care Finance and Economics 9:4, 391-402
    CrossRef

  25. 25

    S. Lutz, P. Hoskin, E. Chow. (2009) Update on Palliative Radiotherapy Endpoints for Bone Metastasis Trials. Clinical Oncology 21:9, 659-661
    CrossRef

  26. 26

    YongJoo Rhee, Howard B. Degenholtz, Anthony T. Lo Sasso, Linda L. Emanuel. (2009) Estimating the Quantity and Economic Value of Family Caregiving for Community-Dwelling Older Persons in the Last Year of Life. Journal of the American Geriatrics Society 57:9, 1654-1659
    CrossRef

  27. 27

    John A Batsis, James M Naessens, Mark T Keegan, Amy E Wagie, Paul M Huddleston, Jeanne M Huddleston. (2009) Impact of body mass on hospital resource use in total hip arthroplasty. Public Health Nutrition 12:08, 1122
    CrossRef

  28. 28

    Emi Sato, Kiyohide Fushimi. (2009) What has influenced patient health-care expenditures in Japan?: variables of age, death, length of stay, and medical care. Health Economics 18:7, 843-853
    CrossRef

  29. 29

    Konrad Fassbender, Robin L. Fainsinger, Mary Carson, Barry A. Finegan. (2009) Cost Trajectories at the End of Life: The Canadian Experience. Journal of Pain and Symptom Management 38:1, 75-80
    CrossRef

  30. 30

    Lisa R. Shugarman, Sandra L. Decker, Anita Bercovitz. (2009) Demographic and Social Characteristics and Spending at the End of Life. Journal of Pain and Symptom Management 38:1, 15-26
    CrossRef

  31. 31

    Henriette Engberg, Anna Oksuzyan, Bernard Jeune, James W. Vaupel, Kaare Christensen. (2009) Centenarians - a useful model for healthy aging? A 29-year follow-up of hospitalizations among 40 000 Danes born in 1905. Aging Cell 8:3, 270-276
    CrossRef

  32. 32

    Andrew M. Ryan. (2009) Effects of the Premier Hospital Quality Incentive Demonstration on Medicare Patient Mortality and Cost. Health Services Research 44:3, 821-842
    CrossRef

  33. 33

    Nora Janjan, Stephen T. Lutz, John M. Bedwinek, William F. Hartsell, Richard S. Pieters, Edward B. Silberstein, Alan W. Yasko. (2009) Clinical Trials and Socioeconomic Implication in the Treatment of Bone Metastasis: A Report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology. Journal of Palliative Medicine 12:5, 427-431
    CrossRef

  34. 34

    Nora Janjan, Stephen T. Lutz, John M. Bedwinek, William F. Hartsell, Andrea Ng, Richard S. Pieters, Vaneerat Ratanatharathorn, Edward B. Silberstein, Robert J. Taub, Alan W. Yasko, Andrew Rettenmaier. (2009) Therapeutic Guidelines for the Treatment of Bone Metastasis: A Report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology. Journal of Palliative Medicine 12:5, 417-426
    CrossRef

  35. 35

    Margaret L. Holland, Alissa Huston, Katia Noyes. (2009) Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes. Value in Health 12:2, 207-216
    CrossRef

  36. 36

    Hwa-Joon Kim, Young Koh, Eun-Jeong Chun, Soong-Nang Jang, Chang-Yup Kim. (2009) Subjective Satisfaction with Medical Care among Older People: Comprehensiveness, General Satisfaction and Accessibility. Journal of Preventive Medicine and Public Health 42:1, 35
    CrossRef

  37. 37

    Uta Ziegler, Gabriele Doblhammer. (2008) Cohort Changes in the Incidence of Care Need in West Germany Between 1986 and 2005. European Journal of Population / Revue européenne de Démographie 24:4, 347-362
    CrossRef

  38. 38

    S. T. Tang, S.-C. Wu, Y.-N. Hung, E.-W. Huang, J.-S. Chen, T.-W. Liu. (2008) Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000-2006. Annals of Oncology 20:2, 343-348
    CrossRef

  39. 39

    R. N. Caskey, M. M. Davis. (2008) Differences associated with age, transfer status, and insurance coverage in end-of-life hospital care for children. Journal of Hospital Medicine 3:5, 376-383
    CrossRef

  40. 40

    K. R. Yabroff, E. B. Lamont, A. Mariotto, J. L. Warren, M. Topor, A. Meekins, M. L. Brown. (2008) Cost of Care for Elderly Cancer Patients in the United States. JNCI Journal of the National Cancer Institute 100:9, 630-641
    CrossRef

  41. 41

    Lisa R. Shugarman, Chloe E. Bird, Cynthia R. Schuster, Joanne Lynn. (2008) Age and Gender Differences in Medicare Expenditures and Service Utilization at the End of Life for Lung Cancer Decedents. Women's Health Issues 18:3, 199-209
    CrossRef

  42. 42

    Baoping Shang, Dana Goldman. (2008) Does age or life expectancy better predict health care expenditures?. Health Economics 17:4, 487-501
    CrossRef

  43. 43

    Charles E. Gessert, Irina V. Haller. (2008) Medicare Hospital Charges in the Last Year of Life: Distribution by Quarter for Rural and Urban Nursing Home Decedents With Cognitive Impairment. The Journal of Rural Health 24:2, 154-160
    CrossRef

  44. 44

    Paula M. Podrazik, Chad T. Whelan. (2008) Acute Hospital Care for the Elderly Patient: Its Impact on Clinical and Hospital Systems of Care. Medical Clinics of North America 92:2, 387-406
    CrossRef

  45. 45

    Hui-Chu Lang, Jaw-Ching Wu, Sang-Hue Yen, Chung-Fu Lan, Shi-Liang Wu. (2008) The Lifetime Cost of Hepatocellular Carcinoma. Applied Health Economics and Health Policy 6:1, 55-65
    CrossRef

  46. 46

    AMBER E. BARNATO. (2007) End-of-life spending: can we rationalise costs?. Critical Quarterly 49:3, 84-92
    CrossRef

  47. 47

    Andreas Werblow, Stefan Felder, Peter Zweifel. (2007) Population ageing and health care expenditure: a school of ‘red herrings’?. Health Economics 16:10, 1109-1126
    CrossRef

  48. 48

    Eswar Krishnan, James F. Fries, C. Kent Kwoh. (2007) Primary knee and hip arthroplasty among nonagenarians and centenarians in the United States. Arthritis & Rheumatism 57:6, 1038-1042
    CrossRef

  49. 49

    Richard Brumley, Susan Enguidanos, Paula Jamison, Rae Seitz, Nora Morgenstern, Sherry Saito, Jan McIlwane, Kristine Hillary, Jorge Gonzalez. (2007) Increased Satisfaction with Care and Lower Costs: Results of a Randomized Trial of In-Home Palliative Care. Journal of the American Geriatrics Society 55:7, 993-1000
    CrossRef

  50. 50

    GREG PAYNE, AUDREY LAPORTE, RAISA DEBER, PETER C. COYTE. (2007) Counting Backward to Health Care's Future: Using Time-to-Death Modeling to Identify Changes in End-of-Life Morbidity and the Impact of Aging on Health Care Expenditures. The Milbank Quarterly 85:2, 213-257
    CrossRef

  51. 51

    Irina V. Haller, Charles E. Gessert. (2007) Utilization of Medical Services at the End of Life in Older Adults with Cognitive Impairment: Focus on Outliers. Journal of Palliative Medicine 10:2, 400-407
    CrossRef

  52. 52

    Kenneth Pietz, Laura A. Petersen. (2007) Comparing Self-Reported Health Status and Diagnosis-Based Risk Adjustment to Predict 1- and 2 to 5-Year Mortality. Health Services Research 42:2, 629-643
    CrossRef

  53. 53

    Patrice K. Nicholas, Mary F. Smith. (2007) Demographic challenges and health in Germany. Population Research and Policy Review 25:5-6, 479-487
    CrossRef

  54. 54

    Amber E. Barnato, Chung-Chou H. Chang, Olga Saynina, Alan M. Garber. (2007) Influence of Race on Inpatient Treatment Intensity at the End of Life. Journal of General Internal Medicine 22:3, 338-345
    CrossRef

  55. 55

    Lisa R. Shugarman, Chloe E. Bird, Cynthia R. Schuster, Joanne Lynn. (2007) Age And Gender Differences in Medicare Expenditures at The End of Life for Colorectal Cancer Decedents. Journal of Women's Health 16:2, 214-227
    CrossRef

  56. 56

    Leslie S. Wilson, Ross Tesoro, Eric P. Elkin, Natalia Sadetsky, Jeanette M. Broering, David M. Latini, Janeen DuChane, Reema R. Mody, Peter R. Carroll. (2007) Cumulative cost pattern comparison of prostate cancer treatments. Cancer 109:3, 518-527
    CrossRef

  57. 57

    Young Ho Yun, Miyoung Kwak, Sang Min Park, Samyong Kim, Jong Soo Choi, Ho-Yeong Lim, Chang Geol Lee, Youn Seon Choi, Young Seon Hong, Si-Young Kim, Dae Seog Heo. (2007) Chemotherapy Use and Associated Factors among Cancer Patients near the End of Life. Oncology 72:3-4, 164-171
    CrossRef

  58. 58

    Chester A. Robinson, Thomas Hoyer, Carol Blackford. (2007) The Continuing Evolution of Medicare Hospice Policy. Public Administration Review 67:1, 127-134
    CrossRef

  59. 59

    Ruth L. Lagman, Declan Walsh, Chad Kunkle, Susan B. LeGrand, Mellar P. Davis. (2006) Deaths in an Academic Medical Center. Journal of Palliative Medicine 9:6, 1260-1263
    CrossRef

  60. 60

    Lisa A. Honkanen, Alvin I. Mushlin, Mark Lachs, Bruce R. Schackman. (2006) Can Hip Protector Use Cost-Effectively Prevent Fractures in Community-Dwelling Geriatric Populations?. Journal of the American Geriatrics Society 54:11, 1658-1665
    CrossRef

  61. 61

    Johan J. Polder, Jan J. Barendregt, Hans van Oers. (2006) Health care costs in the last year of life—The Dutch experience. Social Science & Medicine 63:7, 1720-1731
    CrossRef

  62. 62

    Paul E. Marik. (2006) Management of the critically ill geriatric patient. Critical Care Medicine 34:Suppl, S176-S182
    CrossRef

  63. 63

    Cheryl Fahlman, Joanne Lynn, Danielle Doberman, Jon Gabel, Mike Finch. (2006) Prescription Drug Spending for Medicare+Choice Beneficiaries in the Last Year of Life. Journal of Palliative Medicine 9:4, 884-893
    CrossRef

  64. 64

    Charles E. Gessert, Irina V. Haller, Robert L. Kane, Howard Degenholtz. (2006) RuralâUrban Differences in Medical Care for Nursing Home Residents with Severe Dementia at the End of Life. Journal of the American Geriatrics Society 54:8, 1199-1205
    CrossRef

  65. 65

    Karl A. Lorenz, Lisa R. Shugarman, Joanne Lynn. (2006) Health Care Policy Issues in End-of-Life Care. Journal of Palliative Medicine 9:3, 731-748
    CrossRef

  66. 66

    M. H.-J. Winter, A. Maaz, A. Kuhlmey. (2006) Ambulante und stationäre medizinische Versorgung im Alter. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 49:6, 575-582
    CrossRef

  67. 67

    Stefan Felder. (2006) Lebenserwartung, medizinischer Fortschritt und Gesundheitsausgaben: Theorie und Empirie. Perspektiven der Wirtschaftspolitik 7:s1, 49-73
    CrossRef

  68. 68

    DAVID JOHNSON, JONGSAY YONG. (2006) COSTLY AGEING OR COSTLY DEATHS? UNDERSTANDING HEALTH CARE EXPENDITURE USING AUSTRALIAN MEDICARE PAYMENTS DATA*. Australian Economic Papers 45:1, 57-74
    CrossRef

  69. 69

    Nora Janjan. (2006) Palliation and Supportive Care in Radiation Medicine. Hematology/Oncology Clinics of North America 20:1, 187-211
    CrossRef

  70. 70

    Robert L. Umlauf, Gregory J. Orloff. (2006) Ovarian Cancer Care: A Case Study in Determined Living. Onkologie 29:1-2, 27-29
    CrossRef

  71. 71

    Andrew J. Rettenmaier, Zijun Wang. (2006) Persistence in Medicare reimbursements and personal medical accounts. Journal of Health Economics 25:1, 39-57
    CrossRef

  72. 72

    Anita Bercovitz, Ann L. Gruber-Baldini, Lynda C. Burton, J. Richard Hebel. (2005) Healthcare Utilization of Nursing Home Residents: Comparison Between Decedents and Survivors. Journal of the American Geriatrics Society 53:12, 2069-2075
    CrossRef

  73. 73

    Sharyn N. Lewin, Barbara M. Buttin, Matthew A. Powell, Randall K. Gibb, Janet S. Rader, David G. Mutch, Thomas J. Herzog. (2005) Resource utilization for ovarian cancer patients at the end of life: How much is too much?. Gynecologic Oncology 99:2, 261-266
    CrossRef

  74. 74

    James L. Werth. (2005) Becky's Legacy: Personal and Professional Reflections on Loss and Hope. Death Studies 29:8, 687-736
    CrossRef

  75. 75

    YA-CHEN TINA SHIH, AMY GUO, PAUL M JUST, SALIM MUJAIS. (2005) Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney International 68:1, 319-329
    CrossRef

  76. 76

    Peter Zweifel, Lukas Steinmann, Patrick Eugster. (2005) The Sisyphus Syndrome in Health Revisited. International Journal of Health Care Finance and Economics 5:2, 127-145
    CrossRef

  77. 77

    K. McGarry, R. F. Schoeni. (2005) Widow(er) Poverty and Out-of-Pocket Medical Expenditures Near the End of Life. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 60:3, S160-S168
    CrossRef

  78. 78

    Evelyn L Forget, Raisa B Deber, Leslie L Roos, Randy Walld. (2005) Canadian Health Reform: A Gender Analysis. Feminist Economics 11:1, 123-141
    CrossRef

  79. 79

    Lisa A. Honkanen, Bruce R. Schackman, Alvin I. Mushlin, Mark S. Lachs. (2005) A Cost-Benefit Analysis of External Hip Protectors in the Nursing Home Setting. Journal of the American Geriatrics Society 53:2, 190-197
    CrossRef

  80. 80

    Amber E. Barnato, Renee E. Labor, Nancy E. Freeborne, Robert L. Jayes, Diane E. Campbell, Joanne Lynn. (2005) Qualitative Analysis of Medicare Claims in the Last 3 Years of Life: A Pilot Study. Journal of the American Geriatrics Society 53:1, 66-73
    CrossRef

  81. 81

    Joseph Biskupiak, Eli Komer. (2005) Assessing the Value of Hospice Care. Journal of Pain and Palliative Care Pharmacotherapy 19:4, 61-65
    CrossRef

  82. 82

    G. Nachtigal. (2005) Chirurgie im Alter aus Sicht der Krankenkassen. Der Chirurg 76:1, 19-27
    CrossRef

  83. 83

    Ilija Batljan, Mårten Lagergren. (2004) Inpatient/outpatient health care costs and remaining years of life—effect of decreasing mortality on future acute health care demand. Social Science & Medicine 59:12, 2459-2466
    CrossRef

  84. 84

    Nasreen Dhanani, June F. O'Leary, Emmett Keeler, Anil Bamezai, Glenn Melnick. (2004) The Effect of HMOs on the Inpatient Utilization of Medicare Beneficiaries. Health Services Research 39:5, 1607-1628
    CrossRef

  85. 85

    Peter Zweifel, Stefan Felder, Andreas Werblow. (2004) Population Ageing and Health Care Expenditure: New Evidence on the "Red Herring". Geneva Papers on Risk and Insurance - Issues and Practice 29:4, 652-666
    CrossRef

  86. 86

    Susan C. Miller, Orna Intrator, Pedro Gozalo, Jason Roy, Janet Barber, Vincent Mor. (2004) Government Expenditures at the End of Life for Short- and Long-Stay Nursing Home Residents: Differences by Hospice Enrollment Status. Journal of the American Geriatrics Society 52:8, 1284-1292
    CrossRef

  87. 87

    JESSIE X. FAN, CATHLEEN D. ZICK. (2004) The Economic Burden of Health Care, Funeral, and Burial Expenditures at the End of Life. Journal of Consumer Affairs 38:1, 35-55
    CrossRef

  88. 88

    Berhanu Alemayehu, Kenneth E. Warner. (2004) The Lifetime Distribution of Health Care Costs. Health Services Research 39:3, 627-642
    CrossRef

  89. 89

    D. B. Reuben, T. E. Seeman, E. Keeler, R. P. Hayes, L. Bowman, A. Sewall, S. H. Hirsch, R. B. Wallace, J. M. Guralnik. (2004) The Effect of Self-Reported and Performance-Based Functional Impairment on Future Hospital Costs of Community-Dwelling Older Persons. The Gerontologist 44:3, 401-407
    CrossRef

  90. 90

    Gerald F. Riley. (2004) The Cost of Eliminating the 24-Month Medicare Waiting Period for Social Security Disabled-Worker Beneficiaries. Medical Care 42:4, 387-394
    CrossRef

  91. 91

    Dorothy P. Rice, Norman Fineman. (2004) Economic Implications of Increased Longevity in the United States. Annual Review of Public Health 25:1, 457-473
    CrossRef

  92. 92

    Salmaan Keshavjee. (2004) Medicine and money: the ethical transformation of medical practice. Medical Education 38:3, 271-275
    CrossRef

  93. 93

    M Seshamani. (2004) A longitudinal study of the effects of age and time to death on hospital costs. Journal of Health Economics 23:2, 217-235
    CrossRef

  94. 94

    Melinda Beeuwkes Buntin, Alan M. Garber, Mark Mcclellan, Joseph P. Newhouse. (2004) The Costs of Decedents in the Medicare Program: Implications for Payments to Medicare+Choice Plans. Health Services Research 39:1, 111-130
    CrossRef

  95. 95

    Lisa R. Shugarman, Diane E. Campbell, Chloe E. Bird, Jon Gabel, Thomas A. Louis, Joanne Lynn. (2004) Differences in Medicare Expenditures During the Last 3 Years of Life. Journal of General Internal Medicine 19:2, 127-135
    CrossRef

  96. 96

    Kenneth M Langa, Eric B Larson, Robert B Wallace, A Mark Fendrick, Norman L Foster, Mohammed U Kabeto, David R Weir, Robert J Willis, A Regula Herzog. (2004) Out-of-Pocket Health Care Expenditures Among Older Americans with Dementia. Alzheimer Disease & Associated Disorders 18:2, 90-98
    CrossRef

  97. 97

    J Fran??ois Outreville. (2004) Healthcare Expenditure and Ageing. Applied Health Economics and Health Policy 3:3, 121-123
    CrossRef

  98. 98

    D KESSLER, M MCCLELLAN. (2004) Advance directives and medical treatment at the end of life. Journal of Health Economics 23:1, 111-127
    CrossRef

  99. 99

    Thomas J. Smith, Patrick Coyne, Brian Cassel, Lynne Penberthy, Alison Hopson, Mary Ann Hager. (2003) A High-Volume Specialist Palliative Care Unit and Team May Reduce In-Hospital End-of-Life Care Costs. Journal of Palliative Medicine 6:5, 699-705
    CrossRef

  100. 100

    Stephane Jacobzone. (2003) Ageing and the Challenges of New Technologies: Can OECD Social and Healthcare Systems Provide for the Future?. Geneva Papers on Risk and Insurance - Issues and Practice 28:2, 254-274
    CrossRef

  101. 101

    Irene J Higginson, Ilora G Finlay, Danielle M Goodwin, Kerry Hood, Adrian G.K Edwards, Alison Cook, Hannah-Rose Douglas, Charles E Normand. (2003) Is There Evidence That Palliative Care Teams Alter End-of-Life Experiences of Patients and Their Caregivers?. Journal of Pain and Symptom Management 25:2, 150-168
    CrossRef

  102. 102

    Ateev Mehrotra, R. Adams Dudley, Harold S. Luft. (2003) W HAT'S B EHIND THE H EALTH E XPENDITURE T RENDS ?. Annual Review of Public Health 24:1, 385-412
    CrossRef

  103. 103

    Z. Yang, E. C. Norton, S. C. Stearns. (2003) Longevity and Health Care Expenditures: The Real Reasons Older People Spend More. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 58:1, S2-S10
    CrossRef

  104. 104

    Donald R Hoover, Stephen Crystal, Rizie Kumar, Usha Sambamoorthi, Joel C Cantor. (2002) Medical Expenditures during the Last Year of Life: Findings from the 1992-1996 Medicare Current Beneficiary Survey. Health Services Research 37:6, 1625-1642
    CrossRef

  105. 105

    M. B. Buntin, H. Huskamp. (2002) What Is Known About the Economics of End-of-Life Care for Medicare Beneficiaries?. The Gerontologist 42:Supplement 3, 40-48
    CrossRef

  106. 106

    Chloe E. Bird, Lisa R. Shugarman, Joanne Lynn. (2002) Age and Gender Differences in Health Care Utilization and Spending for Medicare Beneficiaries in Their Last Years of Life. Journal of Palliative Medicine 5:5, 705-712
    CrossRef

  107. 107

    Hilke Brockmann. (2002) Why is less money spent on health care for the elderly than for the rest of the population? Health care rationing in German hospitals. Social Science & Medicine 55:4, 593-608
    CrossRef

  108. 108

    Frank A. Sloan, Donald H. Taylor. (2002) Effect of Alzheimer Disease on the Cost of Treating Other Diseases. Alzheimer Disease & Associated Disorders 16:3, 137-143
    CrossRef

  109. 109

    J. Andrew Billings, Margaret Gardner, Andrew T. Putnam. (2002) A One-Day, Hospital-Wide Survey of Dying Inpatients. Journal of Palliative Medicine 5:3, 363-374
    CrossRef

  110. 110

    June R. Lunney, Joanne Lynn, Christopher Hogan. (2002) Profiles of Older Medicare Decedents. Journal of the American Geriatrics Society 50:6, 1108-1112
    CrossRef

  111. 111

    Thomas E. Finucane. (2002) Care of Patients Nearing Death: Another View. Journal of the American Geriatrics Society 50:3, 551-553
    CrossRef

  112. 112

    Helena Temkin-Greener, Dana B. Mukamel. (2002) Predicting Place of Death in the Program of All-Inclusive Care for the Elderly (PACE): Participant versus Program Characteristics. Journal of the American Geriatrics Society 50:1, 125-135
    CrossRef

  113. 113

    Xavier Badia, Fermin Mearin, Agustin Balboa, Eva Bar??, Ellen Caldwell, Mercedes Cucala, Manuel D??az-Rubio, Arturo Fueyo, Julio Ponce, Mentse Roset, Nicholas J. Talley. (2002) Burden of Illness in Irritable Bowel Syndrome Comparing Rome I and Rome II Criteria. PharmacoEconomics 20:11, 749-758
    CrossRef

  114. 114

    Adrian Jaggi, Christoph Junker, Christoph Minder. (2001) Beeinflusst die medizinische Versorgungsstruktur den Anteil Todesfälle im Spital?. Sozial- und Präventivmedizin SPM 46:6, 379-388
    CrossRef

  115. 115

    Wayne C. McCormick, James Hardy, Walter A. Kukull, James D. Bowen, Linda Teri, Sally Zitzer, Eric B. Larson. (2001) Healthcare Utilization and Costs in Managed Care Patients with Alzheimer's Disease During the Last Few Years of Life. Journal of the American Geriatrics Society 49:9, 1156-1160
    CrossRef

  116. 116

    Katrina A. Bramstedt. (2001) Resisting the blame game: visualizing the high cost of dying and accepting the duty of technology stewardship for all patient populations. A review. Archives of Gerontology and Geriatrics 33:1, 53-59
    CrossRef

  117. 117

    Yang K. Kim, Carleen H. Stoskopf, Saundra H. Glover. (2001) Factors Affecting Total Hospital Charges and Utilization for South Carolina Inpatients with HIV/AIDS in 1994–1996. AIDS Patient Care and STDs 15:5, 277-287
    CrossRef

  118. 118

    Joanne Lynn, Janet Heald Forlini. (2001) "Serious and Complex Illness" in Quality Improvement and Policy Reform for End-of-Life Care. Journal of General Internal Medicine 16:5, 315-319
    CrossRef

  119. 119

    Paul E. Marik, Gary P. Zaloga. (2001) CPR in terminally ill patients?. Resuscitation 49:1, 99-103
    CrossRef

  120. 120

    Peter Pronovost, Derek C. Angus. (2001) Economics of end-of-life care in the intensive care unit. Critical Care Medicine 29:Supplement, N46-N51
    CrossRef

  121. 121

    N. Barzilai, A. R. Shuldiner. (2001) Searching for Human Longevity Genes: The Future History of Gerontology in the Post-genomic Era. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 56:2, M83-M87
    CrossRef

  122. 122

    S Felder. (2000) Health care expenditure in the last months of life. Journal of Health Economics 19:5, 679-695
    CrossRef

  123. 123

    Philippe Geissbühler, Bernadette Mermillod, Charles-Henri Rapin. (2000) Elevated Serum Vitamin B12 Levels Associated With CRP as a Predictive Factor of Mortality in Palliative Care Cancer Patients. Journal of Pain and Symptom Management 20:2, 93-103
    CrossRef

  124. 124

    Andrew A. Quartin, Roland M. H. Schein, Daniel H. Kett, Peter N. Peduzzi. (2000) Prior healthcare utilization as a predictor of survival for medical intensive care unit patients. Critical Care Medicine 28:8, 3053-3059
    CrossRef

  125. 125

    Christian Kronborg Andersen, Kjeld Andersen, Per Kragh-Srensen. (2000) Cost function estimation: the choice of a model to apply to dementia. Health Economics 9:5, 397-409
    CrossRef

  126. 126

    Nicole Makosky Fowler, Joanne Lynn. (2000) Potential Medicare Reimbursements for Services to Patients with Chronic Fatal Illnesses. Journal of Palliative Medicine 3:2, 165-180
    CrossRef

  127. 127

    Michael J. Long, Brenda Stevenson Marshall. (2000) The relationship of impending death and age category to treatment intensity in the elderly. Journal of Evaluation in Clinical Practice 6:1, 63-70
    CrossRef

  128. 128

    Paul E. Marik, Joseph Varon, Alan Lisbon, Harvey S. Reich. (1999) Physicians’ own preferences to the limitation and withdrawal of life-sustaining therapy. Resuscitation 42:3, 197-201
    CrossRef

  129. 129

    Betty R. Ferrell. (1999) The Marriage: Geriatrics and Oncology. Geriatric Nursing 20:5, 238-240
    CrossRef

  130. 130

    Peter Zweifel, Stefan Felder, Markus Meiers. (1999) Ageing of population and health care expenditure: a red herring?. Health Economics 8:6, 485-496
    CrossRef

  131. 131

    David M Cutler, Louise Sheiner. (1999) The Geography of Medicare. American Economic Review 89:2, 228-233
    CrossRef

  132. 132

    Joan M Teno, Ira Byock, Marilyn J Field. (1999) Research Agenda for Developing Measures to Examine Quality of Care and Quality of Life of Patients Diagnosed with Life-Limiting Illness. Journal of Pain and Symptom Management 17:2, 75-82
    CrossRef

  133. 133

    Russell, Louise B., . (1998) Prevention and Medicare Costs. New England Journal of Medicine 339:16, 1158-1160
    Full Text

  134. 134

    René C.J.A. van Vliet, Leida M. Lamers. (1998) The High Costs of Death: Should Health Plans Get Higher Payments When Members Die?. Medical Care 36:10, 1451-1460
    CrossRef

  135. 135

    Thomas J. Smith, Lowell J. Schnipper. (1998) The American Society of Clinical Oncology Program to Improve End-of-Life Care. Journal of Palliative Medicine 1:3, 221-230
    CrossRef

  136. 136

    J. Anne Hallward, Larry Ronan, J. Andrew Billings. (1998) When the Patient Dies: A Survey of Medical Housestaff about Care after Death. Journal of Palliative Medicine 1:3, 231-239
    CrossRef

  137. 137

    Emanuel, Ezekiel J., Battin, Margaret P., . (1998) What Are the Potential Cost Savings from Legalizing Physician-Assisted Suicide?. New England Journal of Medicine 339:3, 167-172
    Full Text

  138. 138

    Mustard, Cameron A., Kaufert, Patricia, Kozyrskyj, Anita, Mayer, Teresa. (1998) Sex Differences in the Use of Health Care Services. New England Journal of Medicine 338:23, 1678-1683
    Full Text

  139. 139

    David P. Paul, Earl D. Honeycutt, Christopher B. Colbum. (1998) Medicare. Health Marketing Quarterly 15:1, 69-93
    CrossRef

  140. 140

    Marie Demers. (1998) Age Differences in the Rates and Costs of Medical Procedures and Hospitalization during the Last Year of Life. Canadian Journal on Aging / La Revue canadienne du vieillissement 17:02, 186-196
    CrossRef

  141. 141

    Sara Carmel, Elizabeth Mutran. (1997) Wishes regarding the use of life-sustaining treatments among elderly persons in Israel: An explanatory model. Social Science & Medicine 45:11, 1715-1727
    CrossRef

  142. 142

    Elizabeth A. Lonberger, Cynthia L. Russell, Suzanne M. Burton. (1997) The Effects of Palliative Care on Patient Charges. The Journal of Nursing Administration 27:11, 23-26
    CrossRef

  143. 143

    R L Kane, B Friedman. (1997) State variations in Medicare expenditures.. American Journal of Public Health 87:10, 1611-1619
    CrossRef

  144. 144

    Maarten J. Postma, Keith Tolley, Reiner M. Leidl, Angela M. Downs, Eduard J. Beck, Andrea M. Tramarin, Yves A. Flori, Miguel Santin, Fernando Antoñanzas, Helen Kornarou, Vasili C.C. Paparizos, Marcel G.W. Dijkgraaf, Jan Borleffs, August J.P. Luijben, Johannes C. Jager. (1997) Hospital care for persons with AIDS in the European Union. Health Policy 41:2, 157-176
    CrossRef

  145. 145

    Stefan Felder. (1997) Costs of dying: alternatives to rationing. Health Policy 39:2, 167-176
    CrossRef

  146. 146

    B Experton, Z Li, L G Branch, R J Ozminkowski, D M Mellon-Lacey. (1997) The impact of payor/provider type on health care use and expenditures among the frail elderly.. American Journal of Public Health 87:2, 210-216
    CrossRef

  147. 147

    Jaume Puig Junoy. (1997) Measuring technical efficiency of output quality in intensive care units. International Journal of Health Care Quality Assurance 10:3, 117-124
    CrossRef

  148. 148

    Marc D. Silverstein, Terrence L. Cascino, William S. Harmsen. (1996) High-Grade Astrocytomas: Resource Use, Clinical Outcomes, and Cost of Care. Mayo Clinic Proceedings 71:10, 936-944
    CrossRef

  149. 149

    Ruth Etzioni, Nicole Urban, Mary Baker. (1996) Estimating the costs attributable to a disease with application to ovarian cancer. Journal of Clinical Epidemiology 49:1, 95-103
    CrossRef

  150. 150

    Sandy C. Marks. (1996) Information technology, medical education, and anatomy for the twenty-first century. Clinical Anatomy 9:5, 343-348
    CrossRef

  151. 151

    A. Joseph Layon, Beverly E. George, Brenda Hamby, T. James Gallagher. (1995) Do elderly patients overutilize healthcare resources and benefit less from them than younger patients? A study of patients who underwent craniotomy for treatment of neoplasm. Critical Care Medicine 23:5, 829-834
    CrossRef

  152. 152

    Lubitz, James, Beebe, James, Baker, Colin, . (1995) Longevity and Medicare Expenditures. New England Journal of Medicine 332:15, 999-1003
    Full Text

  153. 153

    Linda L. Emanuel. (1995) The search for low-cost, high-quality care. Journal of General Internal Medicine 10:4, 232-233
    CrossRef

  154. 154

    Barry M. Kinzbrunner. (1995) Ethical dilemmas in hospice and palliative care. Supportive Care in Cancer 3:1, 28-36
    CrossRef

  155. 155

    William W. Parmley. (1994) Death of a friend: “I want to die!”. Journal of the American College of Cardiology 24:1, 267-268
    CrossRef

  156. 156

    Emanuel, Ezekiel J.Emanuel, Linda L.. (1994) The Economics of Dying -- The Illusion of Cost Savings at the End of Life. New England Journal of Medicine 330:8, 540-544
    Full Text

  157. 157

    Jane Foytack, Daniel J. West. (1994) Physician Management Guidelines for Advance Directives with Patients. OMEGA--Journal of Death and Dying 29:2, 165-175
    CrossRef

  158. 158

    Andrew H. Smith. (1993) Age-based rationing: A wrong turn on the road to reform. Ageing International 20:3, 7-11
    CrossRef